Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...
Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.
WARSAW, Poland, April 16, 2025 — Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) described a new mechanism that improves the efficiency of mRNA-based ...